ZIOPHARM Oncology Inc.
$48 M
Secondary/Follow-On
Co-Manager
Co-Manager
Co-Manager
Sole Book-Runner
Co-Manager
Co-Manager
Joint Book-Runner
Sole Book-Runner
Co-Manager
Advisor
Joint Book-Runner